MT2A and acute myeloid leukemia: Therefore, we detected the effects of MT2A gene over-expression or down-expression on HL60 cell proliferation and apoptosis and the related molecular mechanisms, to explore the possibility of MT2A as a therapeutic target biomarker for AML.